Disrupting the Molecular Pathway in Myotonic Dystrophy

oleh: Xiaomeng Xing, Anjani Kumari, Jake Brown, John David Brook

Format: Article
Diterbitkan: MDPI AG 2021-12-01

Deskripsi

Myotonic dystrophy is the most common muscular dystrophy in adults. It consists of two forms: type 1 (DM1) and type 2 (DM2). DM1 is associated with a trinucleotide repeat expansion mutation, which is transcribed but not translated into protein. The mutant RNA remains in the nucleus, which leads to a series of downstream abnormalities. DM1 is widely considered to be an RNA-based disorder. Thus, we consider three areas of the RNA pathway that may offer targeting opportunities to disrupt the production, stability, and degradation of the mutant RNA.